Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

Fusión de soluciones digitales y estado de las máquinas: Asociación global de ANDRITZ y KCF Technologies

(NOTICIA EN BREVE) El grupo tecnológico internacional ANDRITZ y KCF Technologies, un proveedor de soluciones para el estado de las máquinas, se han asociado para ofrecer soluciones integrales a los complejos desafíos de fabricación en la industria de la pulpa … Read the full press release

Merging Digital Solutions and Machine Health: ANDRITZ and KCF Technologies Global Partnership

(IN BRIEF) International technology group ANDRITZ and KCF Technologies, a provider of machine health solutions, have partnered to offer comprehensive solutions to complex manufacturing challenges in the pulp and paper industry. The collaboration merges ANDRITZ’s digital solution platform and KCF’s … Read the full press release

Nuovi progressi nel trattamento del cancro alla prostata: Darolutamide sta per essere approvato nell’UE

Non destinato ai media statunitensi e britannici (NOTIZIA IN BREVE) Il comitato per i medicinali per uso umano dell’Agenzia europea per i medicinali ha raccomandato l’autorizzazione all’immissione in commercio nell’Unione europea di darolutamide, un inibitore orale del recettore degli androgeni, … Read the full press release

New Advancement in Prostate Cancer Treatment: Darolutamide Set to be Approved in EU

Not intended for U.S. and UK Media (IN BRIEF) The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended darolutamide, an oral androgen receptor inhibitor, for marketing authorization in the European Union as a treatment for patients … Read the full press release

Un estudio de la Universidad de Helsinki revela preocupaciones sobre la calidad del aire interior con los robots de desinfección UVGI

(NOTICIA EN BREVE) Un estudio realizado por investigadores del Instituto de Investigación Atmosférica y del Sistema Terrestre de la Universidad de Helsinki encontró que el uso de radiación germicida ultravioleta (UVGI) para desinfectar espacios interiores con lámparas UV puede conducir … Read the full press release

University of Helsinki Study Reveals Indoor Air Quality Concerns with UVGI Disinfection Robots

(IN BRIEF) A study by researchers at the University of Helsinki’s Institute for Atmospheric and Earth System Research found that using ultraviolet germicidal radiation (UVGI) to disinfect indoor spaces with UV lamps can lead to increased concentrations of gases and … Read the full press release

Henkel organizará horas de enfoque en soluciones y asociaciones de electrónica impresa en la feria comercial LOPEC

(NOTICIA EN BREVE) Henkel, un proveedor líder en la industria de materiales y servicios de electrónica impresa, exhibirá su gama de innovaciones de materiales funcionales para electrónica impresa y su amplio ecosistema de socios en la próxima feria comercial LOPEC … Read the full press release

Henkel to Organize Focus Hours on Printed Electronics Solutions and Partnerships at LOPEC Trade Show

(IN BRIEF) Henkel, an industry-leading supplier of printed electronics materials and services, will showcase its range of functional material innovations for printed electronics and its broad ecosystem of partners at the upcoming LOPEC trade show on March 1 and 2 … Read the full press release

Sandoz acquires Mycamine, reinforcing its anti-infectives portfolio

(IN BRIEF) Sandoz, a global leader in off-patent (generic and biosimilar) medicines, has signed an agreement to acquire worldwide product rights for leading systemic antifungal agent Mycamine® (micafungin sodium, Funguard® in Japan) from Astellas. This acquisition will reinforce Sandoz’s hospital … Read the full press release

Sandoz adquiere Mycamine, reforzando su cartera de antiinfecciosos

(NOTICIA EN BREVE) Sandoz, líder mundial en medicamentos sin patente (genéricos y biosimilares), ha firmado un acuerdo para adquirir los derechos de producto a nivel mundial del agente antifúngico sistémico líder Mycamine® (micafungina sódica, Funguard® en Japón) de Astellas. Esta … Read the full press release

EU Funded SUNRISE Project to Strengthen Critical Infrastructure Resilience Against Pandemics and Other Risks

(IN BRIEF) The EU has launched the SUNRISE project, which aims to improve the resilience of critical infrastructures in Europe, including transport, energy, water, and healthcare, against the impact of pandemics and other major risks. The project, which is set … Read the full press release

TUM Researchers Develop New Methods for Investigating Neuronal Patterns in Cognitive Mental Disorders

How can physicians help patients suffering from mental health disorders like chronic pain, depression and stroke? (IN BRIEF) An interdisciplinary team of researchers at TUM is developing new methods to investigate the neuronal patterns underlying cognitive mental disorders such as … Read the full press release

Investigadores de TUM desarrollan nuevos métodos para investigar patrones neuronales en trastornos mentales cognitivos

¿Cómo pueden los médicos ayudar a los pacientes que padecen trastornos de salud mental como dolor crónico, depresión y accidente cerebrovascular? (NOTICIA EN BREVE) Un equipo interdisciplinario de investigadores de TUM está desarrollando nuevos métodos para investigar los patrones neuronales … Read the full press release

Team of Experts from University of Liverpool Spin-Out Sulantrix Using AI and Multi-omics Platforms to Develop New Cancer Treatments

(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines targeting previously untapped classes of pseudoenzymes. The company is led by Professor Patrick Eyers and CEO David Williams, who has … Read the full press release

Équipe d’experts de l’Université de Liverpool Spin-Out Sulantrix utilisant des plateformes d’IA et multi-omiques pour développer de nouveaux traitements contre le cancer

(ACTUALITÉ EN BREF) Une nouvelle société dérivée de découverte de médicaments de l’Université de Liverpool appelée Sulantrix explore de nouveaux médicaments contre le cancer ciblant des classes de pseudoenzymes jusqu’alors inexploitées. La société est dirigée par le professeur Patrick Eyers … Read the full press release

Roche’s Tecentriq and Avastin Combination Offers New Hope for Early-Stage Liver Cancer Patients

Ad hoc announcement pursuant to Art. 53 LR (PRESS RELEASE) BASEL, 19-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives, announced that their combination treatment … Read the full press release

L’association Tecentriq et Avastin de Roche offre un nouvel espoir aux patients atteints d’un cancer du foie à un stade précoce

Annonce ad hoc conformément à l’art. 53LR (COMMUNIQUÉ DE PRESSE) BÂLE, 19-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), un pionnier mondial des produits pharmaceutiques et des diagnostics axé sur l’avancement de la science pour améliorer la vie des … Read the full press release

Boehringer Ingelheim: A Model for Employee Wellbeing in the Corporate World

(PRESS RELEASE) INGELHEIM, 17-Jan-2023 — /EuropaWire/ — Boehringer Ingelheim, one of the world’s leading research-driven pharmaceutical companies with 130 years of experience, has announced it has been named a “Global Top Employer” for the third year in a row by the … Read the full press release

Boehringer Ingelheim: un modelo para el bienestar de los empleados en el mundo corporativo

(COMUNICADO DE PRENSA) INGELHEIM, 17-Jan-2023 — /EuropaWire/ — Boehringer Ingelheim, una de las principales compañías farmacéuticas del mundo impulsadas por la investigación con 130 años de experiencia, ha anunciado que ha sido nombrada “Global Top Employer” por tercer año consecutivo por … Read the full press release

AstraZeneca completes acquisition of Neogene Therapeutics, expanding its portfolio in immuno-oncology

(PRESS RELEASE) CAMBRIDGE, 16-Jan-2023 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced the completion of its acquisition of Neogene Therapeutics Inc. Neogene is a global clinical-stage biotechnology company that specializes in the discovery, … Read the full press release

AstraZeneca completa la adquisición de Neogene Therapeutics, ampliando su cartera en inmunooncología

(COMUNICADO DE PRENSA) CAMBRIDGE, 16-Jan-2023 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), una multinacional británica-sueca farmacéutica y de biotecnología, ha anunciado la finalización de su adquisición de Neogene Therapeutics Inc. Neogene es una compañía global de biotecnología en etapa clínica que … Read the full press release

AstraZeneca’s Tezspire receives EU approval for self-administration in a convenient pre-filled pen for severe asthma patients

(PRESS RELEASE) CAMBRIDGE, 13-Jan-2023 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced that its drug Tezspire (tezepelumab) has been given the green light for self-administration by the European Medicine Agency’s Committee for Medicinal … Read the full press release

Tezspire de AstraZeneca recibe la aprobación de la UE para la autoadministración en una práctica pluma precargada para pacientes con asma grave

(COMUNICADO DE PRENSA) CAMBRIDGE, 13-Jan-2023 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), una multinacional británica-sueco-farmacéutica y biotecnológica, ha anunciado que su fármaco Tezspire (tezepelumab) ha recibido luz verde para la autoadministración por parte del Comité de Medicamentos de Uso Humano (CHMP) … Read the full press release

Roche’s Xofluza: The Breakthrough Influenza Drug Approved for Children in Europe

(PRESS RELEASE) BASEL, 12-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives, has announced that the European Commission has approved Xofluza (baloxavir marboxil), a … Read the full press release

Xofluza de Roche: el fármaco innovador contra la gripe aprobado para niños en Europa

(COMUNICADO DE PRENSA) BASEL, 12-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), un pionero mundial en productos farmacéuticos y diagnóstico centrado en el avance de la ciencia para mejorar la vida de las personas, ha anunciado que la … Read the full press release

Healthcare Leader Johan Folkunger Takes the Helm at DNV Imatis

(PRESS RELEASE) BÆRUM, 9-Jan-2023 — /EuropaWire/ — DNV, the independent energy expert and assurance provider, has announced that Johan Folkunger has been appointed as the new CEO of DNV Imatis, a digital health company that aims to streamline healthcare operations. … Read the full press release

Gesundheitsführer Johan Folkunger übernimmt das Ruder bei DNV Imatis

(PRESSEMITTEILUNG) BÆRUM, 9-Jan-2023 — /EuropaWire/ — DNV, Der unabhängige Energieexperte und Assurance-Anbieter hat bekannt gegeben, dass Johan Folkunger zum neuen CEO von DNV Imatis ernannt wurde, einem digitalen Gesundheitsunternehmen, das sich zum Ziel gesetzt hat, den Gesundheitsbetrieb zu rationalisieren. Folkunger … Read the full press release

Bayer: Viralgen Vector Core Licensed for Large-Scale recombinant adeno-associated virus (rAAV) Gene Therapy Production

(PRESS RELEASE) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), a global enterprise with core competencies in the life science fields of healthcare and nutrition and and one of the largest pharmaceutical companies in the world, has announced … Read the full press release

Bayer: Viralgen Vector Core con licencia para la producción de terapia génica de virus adenoasociados recombinantes (rAAV) a gran escala

(COMUNICADO DE PRENSA) SAN SEBASTIAN, Spain, 9-Jan-2023 — /EuropaWire/ — Bayer (ETR: BAYN), una empresa global con competencias básicas en los campos de las ciencias biológicas de la salud y la nutrición y una de las compañías farmacéuticas más grandes … Read the full press release

DNV expands into digital health market with acquisition of MBI Healthcare Technologies

(PRESS RELEASE) LONDON, 5-Jan-2023 — /EuropaWire/ — DNV, the independent energy expert and assurance provider, has announced it acquired MBI Healthcare Technologies, a UK-based healthcare data assurance company. The acquisition is part of DNV’s strategic expansion into the digital health … Read the full press release